Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians (PRALINE)

January 31, 2013 updated by: GlaxoSmithKline

Measurement of the Changes in Acceptability of Hepatitis B Immunization Among General Practitioners and Open-care Paediatricians

The present study is conducted in order to assess the acceptability of Hepatitis B vaccination in French general practitioners and peadiatricians before and after reimbursement of the paediatric vaccine InfanrixHexa. Two data measurement time points are planned, first before reimbursement and after reimbursement.

Study Overview

Status

Completed

Conditions

Hepatitis B

Intervention / Treatment

Other: Data collection

Detailed Description

The aim of the study is to assess the acceptability of Hepatitis B immunization among general practitioners and open-care paediatricians. This is a national, repeated transversal epidemiological study with two data measurement time-points over a period of two years (T1 in 2009, T2 in 2011, two different samples of physicians) in order to assess immunization practices before introduction of the reimbursement of InfanrixHexa®, during the transition period and then during the period following reimbursement of the vaccine. At each collection time-point, two patient age groups will be investigated: 12-15 months and 24-27 months, thus providing measurements before/after reimbursement.

Study Type

Observational

Enrollment (Actual)

474

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

France
- - Agde cedex, France, 34303
    - GSK Investigational Site
  - Agen, France, 47000
    - GSK Investigational Site
  - Agen cedex, France, 47002
    - GSK Investigational Site
  - Aire sur la lys, France, 62120
    - GSK Investigational Site
  - Aizenay, France, 85190
    - GSK Investigational Site
  - Albi, France, 81000
    - GSK Investigational Site
  - Ales, France, 30100
    - GSK Investigational Site
  - Alleins, France, 13980
    - GSK Investigational Site
  - Amiens, France, 80080
    - GSK Investigational Site
  - Ancenis, France, 44150
    - GSK Investigational Site
  - Andresy, France, 78570
    - GSK Investigational Site
  - Angers, France, 49000
    - GSK Investigational Site
  - Anglet, France, 64600
    - GSK Investigational Site
  - Annecy, France, 74000
    - GSK Investigational Site
  - Annecy le vieux, France, 74940
    - GSK Investigational Site
  - Antony, France, 92160
    - GSK Investigational Site
  - Argenteuil, France, 95100
    - GSK Investigational Site
  - Arles, France, 13200
    - GSK Investigational Site
  - Arnas, France, 69400
    - GSK Investigational Site
  - Arsac, France, 33460
    - GSK Investigational Site
  - Asnieres sur seine, France, 92600
    - GSK Investigational Site
  - Aubagne, France, 13400
    - GSK Investigational Site
  - Aubergenville, France, 78410
    - GSK Investigational Site
  - Aubervilliers, France, 93300
    - GSK Investigational Site
  - Aucamville, France, 31140
    - GSK Investigational Site
  - Auchy les mines, France, 62138
    - GSK Investigational Site
  - Auriol, France, 13390
    - GSK Investigational Site
  - Avignon, France, 84000
    - GSK Investigational Site
  - Bagneux, France, 92220
    - GSK Investigational Site
  - Bagnols sur ceze, France, 30200
    - GSK Investigational Site
  - Bar le duc, France, 55000
    - GSK Investigational Site
  - Barr, France, 67140
    - GSK Investigational Site
  - Beaulieu les loches, France, 37600
    - GSK Investigational Site
  - Beaumont, France, 63110
    - GSK Investigational Site
  - Beaupreau, France, 49600
    - GSK Investigational Site
  - Beausoleil, France, 06240
    - GSK Investigational Site
  - Beauvais, France, 60000
    - GSK Investigational Site
  - Belfort, France, 90000
    - GSK Investigational Site
  - Bellegarde, France, 30127
    - GSK Investigational Site
  - Berre l etang, France, 13130
    - GSK Investigational Site
  - Besancon, France, 25000
    - GSK Investigational Site
  - Bethune, France, 62400
    - GSK Investigational Site
  - Betton, France, 35830
    - GSK Investigational Site
  - Beziers, France, 34500
    - GSK Investigational Site
  - Biarritz, France, 64200
    - GSK Investigational Site
  - Bievres, France, 91570
    - GSK Investigational Site
  - Biganos, France, 33380
    - GSK Investigational Site
  - Biscarrosse, France, 40600
    - GSK Investigational Site
  - Bischheim, France, 67800
    - GSK Investigational Site
  - Bois guillaume cedex, France, 76235
    - GSK Investigational Site
  - Bollene, France, 84500
    - GSK Investigational Site
  - Boos, France, 76520
    - GSK Investigational Site
  - Bordeaux, France, 33200
    - GSK Investigational Site
  - Bordeaux, France, 33300
    - GSK Investigational Site
  - Bosmie l aiguille, France, 87110
    - GSK Investigational Site
  - Boulogne billancourt, France, 92100
    - GSK Investigational Site
  - Bourg en bresse, France, 01000
    - GSK Investigational Site
  - Bousse, France, 57310
    - GSK Investigational Site
  - Brest, France, 29200
    - GSK Investigational Site
  - Bron, France, 69677
    - GSK Investigational Site
  - Bron, France, 69500
    - GSK Investigational Site
  - Bruges cedex, France, 33520
    - GSK Investigational Site
  - Buchy, France, 76750
    - GSK Investigational Site
  - Caen, France, 14000
    - GSK Investigational Site
  - Cambrai, France, 59400
    - GSK Investigational Site
  - Camphin en carembault, France, 59133
    - GSK Investigational Site
  - Cannes, France, 06400
    - GSK Investigational Site
  - Carresse Cassaber, France, 64270
    - GSK Investigational Site
  - Caveirac, France, 30820
    - GSK Investigational Site
  - Cergy, France, 95000
    - GSK Investigational Site
  - Cergy st christophe, France, 95800
    - GSK Investigational Site
  - Cestas, France, 33610
    - GSK Investigational Site
  - Chalamont, France, 01320
    - GSK Investigational Site
  - Challans, France, 85300
    - GSK Investigational Site
  - Chalon sur saone, France, 71100
    - GSK Investigational Site
  - Chambly, France, 60230
    - GSK Investigational Site
  - Champigny sur marne, France, 94500
    - GSK Investigational Site
  - Chanteloup les vignes, France, 78570
    - GSK Investigational Site
  - Chantilly, France, 60500
    - GSK Investigational Site
  - Chartres, France, 28000
    - GSK Investigational Site
  - Chassieu, France, 69680
    - GSK Investigational Site
  - Chateauneuf les martigues, France, 13220
    - GSK Investigational Site
  - Chatenois les forges, France, 90700
    - GSK Investigational Site
  - Chatou, France, 78400
    - GSK Investigational Site
  - Cherbourg - octeville, France, 50130
    - GSK Investigational Site
  - Clamart, France, 92140
    - GSK Investigational Site
  - Clapiers, France, 34830
    - GSK Investigational Site
  - Clermont Ferrand, France, 63000
    - GSK Investigational Site
  - Clermont ferrand, France, 63100
    - GSK Investigational Site
  - Clichy, France, 92110
    - GSK Investigational Site
  - Colmar, France, 68000
    - GSK Investigational Site
  - Colomars, France, 06670
    - GSK Investigational Site
  - Colombelles, France, 14460
    - GSK Investigational Site
  - Combs la ville, France, 77380
    - GSK Investigational Site
  - Compiegne, France, 60200
    - GSK Investigational Site
  - Conde sur noireau, France, 14110
    - GSK Investigational Site
  - Corbeil essonnes, France, 91100
    - GSK Investigational Site
  - Courpiere, France, 63120
    - GSK Investigational Site
  - Creutzwald, France, 57150
    - GSK Investigational Site
  - Crolles, France, 38920
    - GSK Investigational Site
  - Cugnaux, France, 31270
    - GSK Investigational Site
  - Cusset, France, 03300
    - GSK Investigational Site
  - Darnetal, France, 76160
    - GSK Investigational Site
  - Deluz, France, 25960
    - GSK Investigational Site
  - Dessenheim, France, 68600
    - GSK Investigational Site
  - Digne les bains, France, 04000
    - GSK Investigational Site
  - Divonne les bains, France, 01220
    - GSK Investigational Site
  - Domene, France, 38420
    - GSK Investigational Site
  - Domont, France, 95330
    - GSK Investigational Site
  - Draguignan, France, 83300
    - GSK Investigational Site
  - Einvaux, France, 54360
    - GSK Investigational Site
  - Epinal cedex 9, France, 88051
    - GSK Investigational Site
  - Equeurdreville hainneville, France, 50120
    - GSK Investigational Site
  - Esquerdes, France, 62380
    - GSK Investigational Site
  - Essey les Nancy, France, 54270
    - GSK Investigational Site
  - Estrees st denis, France, 60190
    - GSK Investigational Site
  - Evreux, France, 13500
    - GSK Investigational Site
  - Evry, France, 91000
    - GSK Investigational Site
  - Fecamp, France, 76400
    - GSK Investigational Site
  - Fenioux, France, 79160
    - GSK Investigational Site
  - Feurs, France, 42110
    - GSK Investigational Site
  - Figeac, France, 46100
    - GSK Investigational Site
  - Fontaine, France, 38600
    - GSK Investigational Site
  - Fontaine les dijon, France, 21121
    - GSK Investigational Site
  - Fontains, France, 77370
    - GSK Investigational Site
  - Fontenay sous bois, France, 94120
    - GSK Investigational Site
  - Forges les eaux, France, 76440
    - GSK Investigational Site
  - Fouesnant, France, 29170
    - GSK Investigational Site
  - Foussais payre, France, 85240
    - GSK Investigational Site
  - Francheville, France, 69340
    - GSK Investigational Site
  - Fumel, France, 47500
    - GSK Investigational Site
  - Gamarde les bains, France, 40380
    - GSK Investigational Site
  - Gemozac, France, 17260
    - GSK Investigational Site
  - Gondecourt, France, 59147
    - GSK Investigational Site
  - Gonneville la mallet, France, 76280
    - GSK Investigational Site
  - Gouvieux, France, 60270
    - GSK Investigational Site
  - Gouy sous bellonne, France, 62112
    - GSK Investigational Site
  - Gouzeaucourt, France, 59231
    - GSK Investigational Site
  - Grenoble, France, 38000
    - GSK Investigational Site
  - Greoux les bains, France, 04800
    - GSK Investigational Site
  - Grigny, France, 91350
    - GSK Investigational Site
  - Guenange, France, 57310
    - GSK Investigational Site
  - Haguenau, France, 67500
    - GSK Investigational Site
  - Hatten, France, 67690
    - GSK Investigational Site
  - Hesdin, France, 62140
    - GSK Investigational Site
  - Hoenheim, France, 67800
    - GSK Investigational Site
  - Houilles, France, 78800
    - GSK Investigational Site
  - Houplin ancoisne, France, 59263
    - GSK Investigational Site
  - Hyeres, France, 83400
    - GSK Investigational Site
  - Illkirch graffenstaden, France, 67400
    - GSK Investigational Site
  - Istres, France, 13800
    - GSK Investigational Site
  - Jarny, France, 54800
    - GSK Investigational Site
  - Joue les tours, France, 37300
    - GSK Investigational Site
  - L aigle, France, 61300
    - GSK Investigational Site
  - L huisserie, France, 53970
    - GSK Investigational Site
  - La chapelle sur erdre, France, 44240
    - GSK Investigational Site
  - La couronne, France, 16400
    - GSK Investigational Site
  - La creche, France, 79260
    - GSK Investigational Site
  - La garenne colombes, France, 92250
    - GSK Investigational Site
  - La madeleine, France, 59110
    - GSK Investigational Site
  - La meziere, France, 35520
    - GSK Investigational Site
  - La motte servolex, France, 73290
    - GSK Investigational Site
  - La source orleans, France, 45100
    - GSK Investigational Site
  - La talaudiere, France, 42350
    - GSK Investigational Site
  - La voulte sur rhone, France, 07800
    - GSK Investigational Site
  - Lamarche sur saone, France, 21760
    - GSK Investigational Site
  - Lambersart, France, 59130
    - GSK Investigational Site
  - Landivisiau, France, 29400
    - GSK Investigational Site
  - Lanester, France, 56600
    - GSK Investigational Site
  - Langon, France, 33210
    - GSK Investigational Site
  - Laval, France, 53000
    - GSK Investigational Site
  - Le Bouscat, France, 33110
    - GSK Investigational Site
  - Le barp, France, 33114
    - GSK Investigational Site
  - Le cannet, France, 06110
    - GSK Investigational Site
  - Le chesnay, France, 78150
    - GSK Investigational Site
  - Le creusot, France, 71200
    - GSK Investigational Site
  - Le havre, France, 76600
    - GSK Investigational Site
  - Le kremlin bicetre, France, 94270
    - GSK Investigational Site
  - Le lavandou, France, 83980
    - GSK Investigational Site
  - Le palais sur vienne, France, 87410
    - GSK Investigational Site
  - Le passage d' agen, France, 47520
    - GSK Investigational Site
  - Le rheu, France, 35650
    - GSK Investigational Site
  - Les Sables D'olonne, France
    - GSK Investigational Site
  - Les sables d olonne, France, 85100
    - GSK Investigational Site
  - Les ulis, France, 91940
    - GSK Investigational Site
  - Lesquin, France, 59810
    - GSK Investigational Site
  - Lille Cedex, France, 59020
    - GSK Investigational Site
  - Limas, France, 69400
    - GSK Investigational Site
  - Limoges, France, 87000
    - GSK Investigational Site
  - Lingolsheim, France, 67380
    - GSK Investigational Site
  - Lisieux, France, 14100
    - GSK Investigational Site
  - Lognes, France, 77185
    - GSK Investigational Site
  - Lomme, France, 59160
    - GSK Investigational Site
  - Loos en gohelle, France, 62750
    - GSK Investigational Site
  - Lorient, France, 56100
    - GSK Investigational Site
  - Luzinay, France, 38200
    - GSK Investigational Site
  - Lyon, France, 69008
    - GSK Investigational Site
  - Lyon, France, 69003
    - GSK Investigational Site
  - Lyon, France, 69007
    - GSK Investigational Site
  - Lyon, France, 69001
    - GSK Investigational Site
  - Malakoff, France, 92240
    - GSK Investigational Site
  - Mantes la ville, France, 78711
    - GSK Investigational Site
  - Marchenoir, France, 41370
    - GSK Investigational Site
  - Marcq en baroeul, France, 59700
    - GSK Investigational Site
  - Marguerittes, France, 30320
    - GSK Investigational Site
  - Marmande, France, 47200
    - GSK Investigational Site
  - Marnay, France, 70150
    - GSK Investigational Site
  - Marseille, France, 13008
    - GSK Investigational Site
  - Marseille, France, 13009
    - GSK Investigational Site
  - Marseille, France, 13005
    - GSK Investigational Site
  - Marseille, France, 13007
    - GSK Investigational Site
  - Marseille, France, 13012
    - GSK Investigational Site
  - Marseille, France, 13015
    - GSK Investigational Site
  - Martigues, France, 13500
    - GSK Investigational Site
  - Martin eglise, France, 76370
    - GSK Investigational Site
  - Martinsart, France, 59113
    - GSK Investigational Site
  - Mauze sur mignon, France, 79210
    - GSK Investigational Site
  - Meaux, France, 77100
    - GSK Investigational Site
  - Merignac, France, 33700
    - GSK Investigational Site
  - Merkwiller pechelbronn, France, 67250
    - GSK Investigational Site
  - Mery sur oise, France, 95540
    - GSK Investigational Site
  - Metz, France, 57070
    - GSK Investigational Site
  - Meudon, France, 92360
    - GSK Investigational Site
  - Meylan, France, 38240
    - GSK Investigational Site
  - Meyssac, France, 19500
    - GSK Investigational Site
  - Mirecourt, France, 88500
    - GSK Investigational Site
  - Moivrons, France, 54760
    - GSK Investigational Site
  - Molsheim, France, 67120
    - GSK Investigational Site
  - Mondeville, France, 14120
    - GSK Investigational Site
  - Mons en baroeul, France, 59370
    - GSK Investigational Site
  - Montauban, France, 82000
    - GSK Investigational Site
  - Montelimar, France, 26200
    - GSK Investigational Site
  - Monteux, France, 84170
    - GSK Investigational Site
  - Montfermeil, France, 93370
    - GSK Investigational Site
  - Montgeron, France, 91230
    - GSK Investigational Site
  - Montigny le bretonneux, France, 78180
    - GSK Investigational Site
  - Montigny les metz, France, 57950
    - GSK Investigational Site
  - Montoire sur le loir, France, 41800
    - GSK Investigational Site
  - Montpellier, France, 34080
    - GSK Investigational Site
  - Montpellier, France, 34000
    - GSK Investigational Site
  - Montreuil, France, 93100
    - GSK Investigational Site
  - Morlaas, France, 64160
    - GSK Investigational Site
  - Morlaix, France, 29600
    - GSK Investigational Site
  - Mornas, France, 84550
    - GSK Investigational Site
  - Mouans sartoux, France, 06370
    - GSK Investigational Site
  - Moutiers tarentaise, France, 73600
    - GSK Investigational Site
  - Moyeuvre grande, France, 57250
    - GSK Investigational Site
  - Mur de sologne, France, 41230
    - GSK Investigational Site
  - Nanterre, France, 92000
    - GSK Investigational Site
  - Nantes, France, 44300
    - GSK Investigational Site
  - Nemours, France, 77140
    - GSK Investigational Site
  - Neuville sur saone, France, 69250
    - GSK Investigational Site
  - Niort, France, 79000
    - GSK Investigational Site
  - Nogent sur marne, France, 94130
    - GSK Investigational Site
  - Noisy le roi, France, 78590
    - GSK Investigational Site
  - Noyon, France, 60400
    - GSK Investigational Site
  - Obernai, France, 67210
    - GSK Investigational Site
  - Oloron ste marie, France, 64400
    - GSK Investigational Site
  - Orleans, France, 45100
    - GSK Investigational Site
  - Orleans, France, 45000
    - GSK Investigational Site
  - Orthez, France, 64300
    - GSK Investigational Site
  - Oucques, France, 41290
    - GSK Investigational Site
  - Ouistreham, France, 14150
    - GSK Investigational Site
  - Oust, France, 09140
    - GSK Investigational Site
  - Ozoir la ferriere, France, 77330
    - GSK Investigational Site
  - Palaiseau, France, 91120
    - GSK Investigational Site
  - Pamiers, France, 09100
    - GSK Investigational Site
  - Paris, France, 75018
    - GSK Investigational Site
  - Paris, France, 75013
    - GSK Investigational Site
  - Paris, France, 75012
    - GSK Investigational Site
  - Paris, France, 75015
    - GSK Investigational Site
  - Paris, France, 75006
    - GSK Investigational Site
  - Paris, France, 75005
    - GSK Investigational Site
  - Paris, France, 75014
    - GSK Investigational Site
  - Paris, France, 75020
    - GSK Investigational Site
  - Paris, France, 75011
    - GSK Investigational Site
  - Paris, France, 75008
    - GSK Investigational Site
  - Paris, France, 75009
    - GSK Investigational Site
  - Paris, France, 75016
    - GSK Investigational Site
  - Paris, France, France
    - GSK Investigational Site
  - Pau, France, 64000
    - GSK Investigational Site
  - Pau cedex, France, 64075
    - GSK Investigational Site
  - Pertuis, France, 84120
    - GSK Investigational Site
  - Pierrefitte sur sauldre, France, 41300
    - GSK Investigational Site
  - Plouguernevel, France, 22110
    - GSK Investigational Site
  - Pont a mousson, France, 54700
    - GSK Investigational Site
  - Pont l abbe d arnoult, France, 17250
    - GSK Investigational Site
  - Pont ste maxence, France, 60700
    - GSK Investigational Site
  - Pontarlier, France, 25300
    - GSK Investigational Site
  - Pornic, France, 44210
    - GSK Investigational Site
  - Port sur saone, France, 70170
    - GSK Investigational Site
  - Provins, France, 77160
    - GSK Investigational Site
  - Publier, France, 74500
    - GSK Investigational Site
  - Puteaux, France, 92800
    - GSK Investigational Site
  - Quevreville la poterie, France, 76520
    - GSK Investigational Site
  - Raches, France, 59194
    - GSK Investigational Site
  - Rennes, France, 35000
    - GSK Investigational Site
  - Rennes, France, 35200
    - GSK Investigational Site
  - Rennes, France, 35700
    - GSK Investigational Site
  - Reze, France, 44400
    - GSK Investigational Site
  - Rillieux la pape, France, 69140
    - GSK Investigational Site
  - Riom, France, 63200
    - GSK Investigational Site
  - Rivery, France, 80136
    - GSK Investigational Site
  - Roanne, France, 42300
    - GSK Investigational Site
  - Roche la moliere, France, 42230
    - GSK Investigational Site
  - Rodez, France, 12000
    - GSK Investigational Site
  - Romainville, France, 93230
    - GSK Investigational Site
  - Romans sur isere, France, 26100
    - GSK Investigational Site
  - Romille, France, 35850
    - GSK Investigational Site
  - Ronchin, France, 59790
    - GSK Investigational Site
  - Rosieres en santerre, France, 80170
    - GSK Investigational Site
  - Rouen, France, 76000
    - GSK Investigational Site
  - Royan, France, 17200
    - GSK Investigational Site
  - Ruy, France, 38300
    - GSK Investigational Site
  - Sahurs, France, 76113
    - GSK Investigational Site
  - Saint-Aubin, France, 39410
    - GSK Investigational Site
  - Saintes, France, 17100
    - GSK Investigational Site
  - Sanary sur mer, France, 83110
    - GSK Investigational Site
  - Segonzac, France, 16130
    - GSK Investigational Site
  - Segré, France, 49500
    - GSK Investigational Site
  - Selestat, France, 67600
    - GSK Investigational Site
  - Sens, France, 89100
    - GSK Investigational Site
  - Septemes les vallons, France, 13240
    - GSK Investigational Site
  - Serres, France, 05700
    - GSK Investigational Site
  - Sillery, France, 51500
    - GSK Investigational Site
  - Soissons, France, 02200
    - GSK Investigational Site
  - Sorgues, France, 84700
    - GSK Investigational Site
  - St astier, France, 24110
    - GSK Investigational Site
  - St aubin sur scie, France, 76550
    - GSK Investigational Site
  - St brevin les pins, France, 44250
    - GSK Investigational Site
  - St brieuc, France, 22000
    - GSK Investigational Site
  - St chamond, France, 42400
    - GSK Investigational Site
  - St cheron, France, 91530
    - GSK Investigational Site
  - St cloud, France, 92210
    - GSK Investigational Site
  - St cyr au mont d'or, France, 69450
    - GSK Investigational Site
  - St denis, France, 93200
    - GSK Investigational Site
  - St etienne, France, 42100
    - GSK Investigational Site
  - St etienne de montluc, France, 44360
    - GSK Investigational Site
  - St flour, France, 15100
    - GSK Investigational Site
  - St genis laval, France, 69230
    - GSK Investigational Site
  - St germain les arpajon, France, 91180
    - GSK Investigational Site
  - St herblain, France, 44800
    - GSK Investigational Site
  - St ismier, France, 38330
    - GSK Investigational Site
  - St jean, France, 31240
    - GSK Investigational Site
  - St jean de la ruelle, France, 45140
    - GSK Investigational Site
  - St leu la foret, France, 95320
    - GSK Investigational Site
  - St louis, France, 68300
    - GSK Investigational Site
  - St loup sur semouse, France, 70800
    - GSK Investigational Site
  - St malo, France, 35400
    - GSK Investigational Site
  - St nazaire, France, 44600
    - GSK Investigational Site
  - St pierre d irube, France, 64990
    - GSK Investigational Site
  - St pol sur mer, France, 59430
    - GSK Investigational Site
  - St priest, France, 69800
    - GSK Investigational Site
  - St remy de provence, France, 13210
    - GSK Investigational Site
  - St tropez, France, 83990
    - GSK Investigational Site
  - Ste foy la grande, France, 33220
    - GSK Investigational Site
  - Ste maxime, France, 83120
    - GSK Investigational Site
  - Strasbourg, France, 67000
    - GSK Investigational Site
  - Strasbourg, France, 67100
    - GSK Investigational Site
  - Strasbourg cedex, France, 67082
    - GSK Investigational Site
  - Sucy en brie, France, 94370
    - GSK Investigational Site
  - Suresnes, France, 92150
    - GSK Investigational Site
  - Talence, France, 33400
    - GSK Investigational Site
  - Tarascon, France, 13150
    - GSK Investigational Site
  - Thiais, France, 94320
    - GSK Investigational Site
  - Thonon les bains, France, 74200
    - GSK Investigational Site
  - Thun st amand, France, 59158
    - GSK Investigational Site
  - Toul, France, 54200
    - GSK Investigational Site
  - Toulon, France, 83000
    - GSK Investigational Site
  - Toulon, France, 83200
    - GSK Investigational Site
  - Toulouse, France, 31500
    - GSK Investigational Site
  - Tours, France, 37100
    - GSK Investigational Site
  - Trie chateau, France, 60590
    - GSK Investigational Site
  - Troyes, France, 10000
    - GSK Investigational Site
  - Vabres l abbaye, France, 12400
    - GSK Investigational Site
  - Val de vesle, France, 51360
    - GSK Investigational Site
  - Valence, France, 26000
    - GSK Investigational Site
  - Vallauris, France, 06220
    - GSK Investigational Site
  - Vandoeuvre les nancy, France, 54500
    - GSK Investigational Site
  - Vannes, France, 56000
    - GSK Investigational Site
  - Vannes cedex, France, 56034
    - GSK Investigational Site
  - Vaugneray, France, 69670
    - GSK Investigational Site
  - Vaulx en velin, France, 69120
    - GSK Investigational Site
  - Vaureal, France, 95490
    - GSK Investigational Site
  - Vaux le penil, France, 77000
    - GSK Investigational Site
  - Vendargues, France, 34740
    - GSK Investigational Site
  - Vernouillet, France, 78540
    - GSK Investigational Site
  - Versailles, France, 78000
    - GSK Investigational Site
  - Vertou, France, 44120
    - GSK Investigational Site
  - Villars les Dombes, France, 01330
    - GSK Investigational Site
  - Villeblevin, France, 89340
    - GSK Investigational Site
  - Villeneuve d ascq cedex, France, 59658
    - GSK Investigational Site
  - Villeurbanne cedex, France, 69626
    - GSK Investigational Site
  - Villiers sur marne, France, 94350
    - GSK Investigational Site
  - Vincennes, France, 94300
    - GSK Investigational Site
  - Viry chatillon, France, 91170
    - GSK Investigational Site
  - Vitrolles, France, 13127
    - GSK Investigational Site
  - Vitry sur Seine, France, 94400
    - GSK Investigational Site
  - Voreppe, France, 38340
    - GSK Investigational Site
  - Wattignies, France, 59139
    - GSK Investigational Site
  - Yerres, France, 91330
    - GSK Investigational Site
  - Zillisheim, France, 68720
    - GSK Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

Child
Adult
Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

An eligibility register will be kept throughout the inclusion period by the investigators. All children aged 12 to 15 months and 24 to 27 months, seen by the physician during this period, will be entered on this register General practitioners and open-care paediatricians drawn at random and agreeing to participate in the study.

Description

Inclusion Criteria:

• Children on the eligibility register complying with the investigator's immunization policy (children followed by the investigator since their birth, whose immunization regimen has been managed by the investigator).

Exclusion Criteria:

Children on the eligibility register not complying with the investigator's immunization policy.
Refusal of the patient.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Number of groups / cohorts

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Generalist physicians Cohort	Other: Data collection Questionnaire, Vaccination book
Paediatricians Cohort	Other: Data collection Questionnaire, Vaccination book

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Change in the proportion of physicians with at least 50% of infants immunized against Hepatitis B. Time Frame: 4 years	4 years

Secondary Outcome Measures

Outcome Measure	Time Frame
Type of physicians, based on the questionnaire regarding immunization practices and established at each measurement time point. Time Frame: 4 years	4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

GlaxoSmithKline

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2009

Primary Completion (Actual)

April 1, 2012

Study Completion (Actual)

April 1, 2012

Study Registration Dates

First Submitted

January 24, 2013

First Submitted That Met QC Criteria

January 24, 2013

First Posted (Estimate)

January 28, 2013

Study Record Updates

Last Update Posted (Estimate)

February 4, 2013

Last Update Submitted That Met QC Criteria

January 31, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

113385

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hepatitis B

Ain Shams University

Completed

Resistance to Lamivudine in HBV Egyptian Patients

Chronic Hepatitis B Virus Treatment

Egypt
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Gilead Sciences

Not yet recruiting

Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China (GATE)

Chronic Hepatitis b

China
Nanfang Hospital of Southern Medical University

Recruiting

Biomarkers Guided Stopping NAs Treatment

Chronic Hepatitis b

China
IlDong Pharmaceutical Co Ltd

Recruiting

A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo

Chronic Hepatitis b

Korea, Republic of
Antios Therapeutics, Inc

Terminated

Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects

Chronic Hepatitis b

United States
Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Unknown

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

Chronic Hepatitis b
Tongji Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) (Neptune)

Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

The Efficacy and Safety of TAF vs Other NAs in Patients With LVL

Chronic Hepatitis b | Cirrhosis Due to Hepatitis B

China
Tam Anh Research Institute

Active, not recruiting

Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis b | Hepatitis Delta With Hepatitis B Carrier State

Vietnam
Mahidol University

Unknown

HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg

Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine

Thailand

Clinical Trials on Data collection

Care Management Plus

Completed

Enhancing Complex Care Through an Integrated Care Coordination Information System

Health Information Technology | Nurse Based Care Management

United States
GCS Ramsay Santé pour l'Enseignement et la Recherche

Completed

Evaluation of the Incidence of NTRK Gene Fusion in Adult Brain Tumours (NTRK Fusion)

Glioma

France
M.D. Anderson Cancer Center

Unknown

Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics

Pediatric Cancer

United States
GlaxoSmithKline

Completed

To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries

Infections, Streptococcal

Romania, Slovenia, Poland, Lithuania, Estonia
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin

Completed

Loco-regional Complications of Pharyngitis in Children: a National Case-Control Study (CAPE)

Pharyngitis

France
Hospices Civils de Lyon

Completed

Levosimendan for Veno-arterial ECMO Weaning (WEANECMO)

Cardiogenic Shock | Refractory Shock

France
Xuanwu Hospital, Beijing

Recruiting

National, Multicentric Registry Study on Neuroimmunological Diseases in China (NIDBase)

Multiple Sclerosis | Myasthenia Gravis | Autoimmune Encephalitis | Acute Disseminated Encephalomyelitis | NMO Spectrum Disorder | Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

China
Centre Hospitalier Universitaire de Saint Etienne

Recruiting

Study of Cerebral Compliance in Neurosurgical Intensive Care Units (EC2) (EC2)

Cerebrospinal; Disorder

France
Women and Infants Hospital of Rhode Island

Terminated

HMB- Data Collection Methods

Heavy Menstrual Bleeding

United States
Centre Hospitalier Universitaire Dijon

Completed

Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG) (IMPACT)

Coronary Artery Bypass Graft | Anomalies in Glucose Metabolism

France

Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians (PRALINE)

Measurement of the Changes in Acceptability of Hepatitis B Immunization Among General Practitioners and Open-care Paediatricians

Study Overview

Status

Conditions

Intervention / Treatment

Detailed Description

Study Type

Enrollment (Actual)

Contacts and Locations

Study Locations

Participation Criteria

Eligibility Criteria

Ages Eligible for Study

Accepts Healthy Volunteers

Genders Eligible for Study

Sampling Method

Study Population

Description

Study Plan

How is the study designed?

Design Details

Number of groups / cohorts

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure

Time Frame

Secondary Outcome Measures

Outcome Measure

Time Frame

Collaborators and Investigators

Sponsor

Study record dates

Study Major Dates

Study Start

Primary Completion (Actual)

Study Completion (Actual)

Study Registration Dates

First Submitted

First Submitted That Met QC Criteria

First Posted (Estimate)

Study Record Updates

Last Update Posted (Estimate)

Last Update Submitted That Met QC Criteria

Last Verified

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Clinical Trials on Hepatitis B

Clinical Trials on Data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations